Loading Events

« All Events

  • This event has passed.

ICNPB – International Conference on Natural Product Biotechnology

25/09/2017 - 26/09/2017

ICMANNatural Product Biotechnology is a multidisciplinary research, knowledge transfer and business development conference focused on biotechnology and high-value natural products. The aim of NPB is to engage people and organizations from across the life science and biotechnology communities in discussions about natural product resources and feedstocks, sustainable technologies and the circular economy.

The 2017 event will provide a forum to strengthen research and business links and is being held in conjunction with the Joint International Conference on the Mechanism of Action of Nutraceuticals and the International Union of Basic and Clinical Pharmacology, Natural Products Section ICMAN-IUPHAR which takes place on 27-29 September, in the same venue.

There is a very rich programme – here are some of the speakers who have already confirmed:

  • Dr Charlie Bavington, Founder of Glycomar
  • Dr Andrew Mearns Spragg, Founder of Jellagen
  • Dr Jonathan Williams, Pennotec
  • Prof Colin Campbell, Chief Executive of the James Hutton Institute
  • Prof Ian Graham, High Value Chemicals from Plants Network
  • Prof John Pickett, Rothamstead Institute
  • Dr Divaldo Rezende, Sustainable Carbon
  • Prof Shane Ward, Leader of the Agrocycle Project
  • Prof Russ Kerr, University of Prince Edward Island

Find out more about our programme and how to register online at www.icnpb.org – for information about exhibiting or sponsoring, or for general queries, please contact us at contact@icnpb.org

Details

Start:
25/09/2017
End:
26/09/2017
Event Category:
Website:
http://www.icnpb.org​

Organizer

ICNPB
Website:
www.icnpb.org​

Venue

Aberdeen Exhibition and Conference Centre (AECC)
Exhibition Ave, Bridge of Don, Aberdeen AB23 8BL, UK
Aberdeen , 824824 United Kingdom
+ Google Map
Phone:
+44 1224 824824
Website:
https://www.aecc.co.uk/

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.